Search earnings tickers

TMO

2024Q3BMO

Thermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2024-10-23 · Fiscal end 2024-09-30 · Features as of 2024-10-22

← Earnings history

Street

Consensus EPS5.25

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.6%

IV front—

P/C full—

P/C front—

Features as of2024-10-22

Run-up

Close—

Ret 5d-2.4%

Ret 10d-1.5%

Ret 20d-4.2%

Ret 30d-6.1%

Print

Actual EPS

5.28Beat

Estimated EPS5.25

Actual revenue

10.6B

Surprise %+0.6%

Beat / missBeat

Beat streak 44

Beat streak 85

Reaction

1-day stock reaction+0.3%

Implied vs actual

Implied 1.6%Actual 2.0%

Gap reaction-2.0%

Day result-1.7%

Next-day upYes

Realized / IV1.29×

Post tape

Post 5d-4.5%

Post 10d-2.9%

Post volume2.1M

Vol ×10d1.53×

Vol ×20d1.72×

Post range2.2%

TMO

Pre-Earnings Data